David Wierz

David J. Wierz

Principal
Health Sciences
Philadelphia
  • CV (English)
  • Contact Card
  • LinkedIn

David J Wierz focuses on optimizing commercial strategy, value in use, market access & payment for the life sciences. He leverages data and analytics to create strategic roadmaps for clinical development, product commercialization and in-market management. David links work in the life sciences with advising payers, providers and other healthcare system players on adoption and use of new technologies in delivering value-based care. His work applies expertise in economic modeling, pricing, contracting and reimbursement to enhance value in service delivery and margin with early stage to Fortune 50 companies.

David’s leadership encompasses roles defining commercial pathways that optimizes access, use, pricing & payment across US and Global operations. Delivery includes products and services integrating Digital Health (J&J, Biosign, Life Navigator), Care Delivery (ECRI, TakeCare, SSM) and Payment (MedImpact, IBX) with Devices, Diagnostics, Therapeutics & Vaccines (Pfizer, Baxalta, Novartis, Takada, J&J) thru building Data-Driven Solutions (IQVIA, Symphony, Health Catalyst).

Key Contributions

Achieve Year One revenues of $34 Million to $362 Million by defining product value. Design, develop and deliver the go-to-market strategy integrated with product economics and evidence that secures access, use, payment and price across Government and commercial payers in the US and Globally

Secure 6% CAGR for Medicare Advantage, Managed Medicaid and commercial plans applying dynamic systems to integrates benefit design, consumer behavior and member segmentation to build and deliver individual activation that optimizes care plus costs across LOB and sites of service

Deliver 15%+ reduction in total costs with 30% gain in through-put by applying digital technologies & exception-based algorithms implementing management systems for remote patient management. Deploy to support performance-based contracts for orthopedics as well as chronic & post-acute care

Achieve annual revenue targets of $15 to $80 Million by triaging, restructuring and leading sales & account management teams. Refocus marketing and sales process on client and customer-focused solution sales delivering improved market performance across consumers, providers & payers

Establish commercial development and analytics infrastructures increasing EBITDA by 4% to 8% thru unifying analytics & data to implement systems and controls that enhance market intelligence, risk stratification, contracting & revenue management with products and service in the US and Globally

CREDENTIALS & PROFESSIONAL HONORS

  • M.A., Public Policy Management, Wharton Kennedy School of Public Policy, University of Pennsylvania
  • B.A., Political Science, University of Chicago

Publications

Peer-Reviewed Publications

“Error by Omission - A lack of Inclusion Among Clinical & Support Staff in Preparing and Negotiating Health IT Contracts,” Health Informatics Journal, A Sage Publication, DOI: 10.1177/1460458219898095, 2020 (with T.R. Martin, H. Gasoyan)

“A Framework for Contracted Health IT Performance Assessments,” Hospital Topics, 97:1, 15-22, DOI: 10.1080/00185868.2018.1556371, 2019 (with T.R. Martin, H. Gasoyan)

“Applying System Engineering to Pharmaceutical Safety,” Journal of Healthcare Engineering, Vol. 3, No. 3, pp. 391-414, September 2012 (with N. Levenson, M. Couturier, J. Thomas, M. Dierks, B. Psaty, S. Finkelstein)

“The Use of Disease-Modifying New Drugs for Multiple Sclerosis Treatment in Private-Sector Health Plans,” Clinical Therapeutics, Vol. 26, No. 8, 1341-1354, 2004 (with RJ Ozminkowski, WD Marder, K Hawkins, S Wang, SC Stallings, SN Finkelstein, and AJ Sinskey)

“A Cost-Cost Study Comparing Entanercept with Infliximab in Rheumatoid Arthritis,” Pharmacoeconomics, Vol. 19, No. 10, pp. 1051–1064, 2001 (with M.J.C. Nuijten, P. Engelfriet, K. Duijn, G. Bruijn, and M. Koopmanschap)

“Cost, Price, and Profit of Branded and Generic Medications,” Journal of the American Medical Association (JAMA), November 16, 1986 (with B. Bloom and M.V. Pauly)

Published Work

“Outbreak Response in Aging Services – Minimizing Mortality, Maximizing Continuing Operations thru Cohorting & Unit Design,” ECRI (Emergency Care Research Institute), April 2021 (with B. Andress, J. Davis IV, J. Nuber, V. Rose)

“A Framework for Implementing Telehealth,” Telehealth Workgroup, wedi (Workgroup for Electronic Data Interchange), November 2020 (with Alison Armstrong, Nancy Spector)

“Overcoming Barriers to the Broader Adoption of Telehealth,” Telehealth Workgroup, wedi (Workgroup for Electronic Data Interchange), 9 April 2020 (with Alison Armstrong, Nancy Spector, Alexander Altman, Marilyn Zigmund Luke)

“Telehealth Modalities,” Innovative Encounters Workgroup, wedi (Workgroup for Electronic Data Interchange), 22 January 2018 (with N. Spector, H. Dix, D. Haugen, D. Rodriguez, S. Whitney)

“Innovation Pathways – Do Process Management Methods Affect Innovation within Organizations?” HIMSS Innovation Pathways Workgroup, Health Information Management Systems Society (HIMSS), February 2014 (with J. Painter, M. Swietlik, L. Miller, P. Dudka, C. Campbell)

“Use Case Study: Johns Hopkins Hospital and Medicine,” Mobile Technology – Revolutionizing Healthcare Series, mHIMSS, Health Information Management Systems Society (HIMSS), June 2013 (with M. Kurliand, J. Christina)

“Use Case Study: CHOP – Children’s Hospital of Philadelphia,” Mobile Technology – Revolutionizing Healthcare Series, mHIMSS, Health Information Management Systems Society (HIMSS), February 2013 (with M. Kurliand, J. Christina, M. Ahmed)

“mHealth – Payment, ROI & Reimbursement,” mHIMSS Roadmap for Mobile Technology Adoption and Use in Healthcare, Health Information Management Systems Society (HIMSS), January 2013 (with C. Wasden)

“Business Models for Financial Sustainability with Health Information Exchanges,” HIE Learning Network, National eHealth Collaborative (NeHC) for the Office of the National Coordinator (ONC) – December 2012 (with J. Rose, M. Sims)

“Defining the Use Case as it’s Related to Mobile Healthcare, Payments & ROI,” mHIMSS Perspective, Health Information Management Systems Society (HIMSS), 28 November 2012

“Impact of mHealth on Quality and Patient Care Outcomes,” Invited Special Topic Fact Sheet. Quality, Cost and Safety Committee, Health Information Management Systems Society (HIMSS), June 2012 (with D. Milov)

“Analyzing the Efficacy of Regulatory Reform using System Engineering – The Vioxx Case,” MIT Center for Biomedical Innovation (CBI) and Engineering Systems Division Working Paper, June 2010 (with N. Levenson, S. Finkelstein, M. Couturier and B. Psaty)

“Big Pharma’s Secret Weapon: Medicare Starts to Pay-Off – Quietly,” The RPM (Regulation, Policy, Market Access) Report, Vol. 1, No. 8, August 2006

“Demand-Side Pharmacoeconomics,” Pharmaceutical Outcomes News - A Monthly Report for Pharmaceutical Executives, Vol. 3, No. 12, December 1994

“Squeeze Pay-Reductions in Payment, Managed Care and Disease Management,” Drug Topics, September 1994

“The Agency of the Nineties,” Pharmaceutical Executive, April 1994 (with S.A. Flaum)

Presentations

Invited Seminars, Symposia and Workshops

“Planning for Success – Reimbursement, Distribution, Commercialization & Customer Knowledge,” Presenter with A. Green, J. Weinbach, J. Hollander & M. Walchak, PACT (Philadelphia Alliance for Capital & Technologies) – MedTech Series, August 2021

“Disruptive Innovation in Healthcare Delivery,” Moderator & Discussant with R. Davis, C. Michaelidis, J. Shaman & S. Weaver, Health Leadership Network of the Delaware Valley – American College of Healthcare Executives (HLNDV – ACHE), April 2021

“A Framework for Contracted Health IT Performance Assessments,” Presenter with T.R. Martin, PhD, Sessions 305, HIMSS20, Orlando, Florida, March 2020

"Why Medical Product Development Begins with Commercialization,” Presenter & Discussant, Philadelphia Regional Integrated Medicine Alliance (PRIMA), Philadelphia, Pennsylvania, March 2020

“Business Models, Revenue Strategies - Digital Technologies in Health & Care,” Panel Lead, Philadelphia Alliance for Capital & Technologies (PACT) MedTech Series, Philadelphia, Pennsylvania, December 2019

“Oncology Drug Pricing Under Extreme Market Pressures and The Projected Impact on All Stakeholder Channels in the Future,” Panelist & Discussant, 2019 Summit, Association for Value-Based Cancer Care (AVBCC), New York, New York, October 2019

“Paying for New Technology with Inpatient & Outpatient Care,” Organizer & Discussant, Reimbursement & Physician Practice Management Meeting, Health Care Financial Management Association (HFMA) - Philadelphia Chapter, Philadelphia, Pennsylvania, October 2019

“Strategic Use of Real-World Evidence & Data Regarding Quality and Value,” Panelist & Discussant, AdvaMed MedTech Connect, Boston, Massachusetts, September 2019

“Setting Price - With Biopharma, Diagnostics and Devices - Part II - Development & Practice,” Invited Seminar, Society of Actuaries (SOA) Pharmacy Cost Workgroup, Virtual Session, May 2019

“Setting Price - With Biopharma, Diagnostics and Devices - Part I - Process & Components,” Invited Seminar, Society of Actuaries (SOA) Pharmacy Cost Workgroup, Virtual Session, April 2019

“Contracting for Health IT Supporting Pay-for-Performance – Best Practices – Early Findings,” Presenter with T.R. Martin, PhD and H. Gasoyan, DMD, MPH, Fall Meeting, New Jersey & Delaware Valley HIMSS, Atlantic City, New Jersey, September 2018

“Analytics to Support Care and Outcomes,” Facilitator and Lead Discussant, Joint Session – Wharton Healthcare Alumni Association and Harvard Business School Healthcare Alumni Association, New York, New York, August 2015

“Investing in Informatics – Using Big Data in Practice,” Panelist and Discussant with S.J. Davidson, MD, MBA, FACEP, FACPE, R. Lakhanpal, MD, FRCS, FACEP, R. Cochran and J. Rajda, MD, MBA, Wharton Health Care Management Alumni Association, New York, New York, November 2013

“Defining ROI under Multiple Business Models – The Case for Mobile Technology in Healthcare,” mHIMSS Roadmap: mHealth Guidance for Hospitals & Health Systems, Invited Symposia, HIMSS-2013, New Orleans, Louisiana, March 2013

“Globalization of Bio-Manufacturing: Safety and Economic Ramifications,” Panel Organizer and Facilitator, MIT Center for Biomedical Innovation (CBI) Bio-Manufacturing Summit, Cambridge, Massachusetts, November 2009

“Medicare Part D – Beyond the Speed Bumps – Accelerating for Future Success,” Multi-Session Workshop at the IMS Americas Client Conference, Miami, Florida, May 2006 (with P.J. Cain)

“The Changing Industry and Geopolitical Landscapes,” Invited Seminar, 2005 National Association of Business Economists (NABE) Annual Meeting – Change and Competitiveness: Who Moved My Paradigm? Chicago, Illinois, September 2005 (with D.A Wyss and M.J. Schmitt)

“Capturing the Value of Biopharmaceuticals–Integrating Elements of Pricing and Reimbursement into Clinical Development and Commercialization,” Accepted Workshop, Ninth Annual Meeting, International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Arlington, Virginia, May 2004

Final Reports, Working Papers and Presentations

“Just What are the Barriers to Broader Adoption of Telehealth - Results of the wedi Survey,” TeleHealth Workgroup, wedi (Workgroup for Electronic Data Interchange), 28 March 2019 (with N. Spector, A. Armstrong)

“Biosimilar Products Take Flight,” Almanac 2016 – The Butterfly Effect, YourEncore, Inc., September 2016

“Transforming the Emergency Department from a Loss-Leader to a Profit Center,” Moderator and Respondent, Population Health Summit, November 2015, National Harbor, Maryland (with N. Sikka)

“The Role of Biosensors in Routine Practice,” What’s Next Workgroup, HIMSS mHealth Community, Health Information Management Systems Society, January 2015

“A Look at the Market for Wearable Health & Fitness Devices – and – Drivers for Consumer Adoption,” Consumer Electronics Association (CEA), Invited Session, mHealth Summit 2013, December 2013, National Harbor, Maryland

“eHealth in Practice – Integrating Genetics and Genomics into the Patient-Centered Medical Home (PCMH),” eHealth Workshop, Community Connections in the Medical Neighborhood, Patient-Centered Primary Care Collaborative (PCPCC) Annual Fall Conference, October 2013, Bethesda, Maryland

“Health Information Exchanges – The New Interstate System or Road to Nowhere,” Session Content Development and Moderator, Philadelphia Health Information Technology (PHIT) Circle, October 2013, Philadelphia, Pennsylvania

“Meaningful Use & Change Management,” Monthly Briefing, Management Engineering – Process Improvement Committee, Health Information Management Systems Society (HIMSS), August 2013

“The mHealth Value Chain: Opportunities and Barriers,” mHealth Summit 2012 – Technology | Business | Research | Policy, December 2012, National Harbor, Maryland

“Robotics and Re-Admissions – Applications Today and Tomorrow,” Monthly Briefing, Management Engineering – Process Improvement (ME-PI) Committee, Health Information Management Systems Society (HIMSS), June 2012

“Controlling Hospital Re-Admissions – Applying Information Technologies,” The Hospital Re-Admissions Work Group, Management Engineering–Process Improvement (ME-PI) Committee, Health Information Management Systems Society (HIMSS), February 2012

“New Approaches to Benefits and Benefits Management,” Presented at the Fifth Annual Leadership Summit – National Association of Specialty Health Organizations (NASHO), July 2007, Woodland Hills, California

“The Pharmaceutical Industry and Managed Markets – New Dynamics for Contracting and Commercialization,” Presented at the Data Niche Associates Fall 2006 Drug Rebate Conference, September 2006, Denver, Colorado

“Medicare Part D – A First Look,” Keynote Presentation at the 2006 IMS Americas Client Conference, May 2006, Miami, Florida

“Successful Drug Development – Defining a Development Strategy that Optimizes Clinical and Commercial Value,” Presented at the Biotech Industry Organization (BIO) International Meeting - 2003, June 2003, Washington, D.C. (with A.J. Sinskey, and S.N. Finkelstein)

“The Use of Disease-Altering New Drugs for Multiple Sclerosis Treatment,” Presented at the Annual Meeting of the Academy for Health Services Research and Health Policy, June 2003, Nashville, Tennessee (with R.J. Ozminkowski, W.D. Marder, K. Hawkins, S. Wang, S. Stallings, S. Finkelstein and A. Sinskey)

“The Use of Disease-Altering New Drugs for Multiple Sclerosis Treatment,” Presented at the Eight Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 2003, Washington, D.C. (with R.J. Ozminkowski, W.D. Marder, K. Hawkins, S. Wang, S. Stallings, S. Finkelstein and A. Sinskey)

“Unmet Medical Need - Defining the Clinical and Commercial Opportunity for Biotech Products,” Presented at the Biotech Industry Organization (BIO) International Meeting, Toronto, Ontario, Canada, June 2002 (with A.J. Sinskey, W.D. Marder, S.N. Finkelstein, and S.C. Stallings)

“Maximizing the Potential of Biotechnology - The Product, Profile, Positioning and Value,” Presented at the Biotech Industry Organization (BIO) International Meeting, San Diego, California, June 2001

“Budgetary Impact Analysis for Use in Reimbursement Process of Entanercept in Moderate to Severe Rheumatoid Arthritis,” Presented at the Third Annual European Conference, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Antwerp, Belgium, November 2000 (with M.J.C. Nuijten, P.M. Engelfriet, K.J. Duijn and G. Kiebert)

“A Cost-Cost Study Comparing Enbrel with Remicade in Moderate to Severe Rheumatoid Arthritis,” Presented at the Third Annual European Conference, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Antwerp, Belgium, November 2000 (with M.J.C. Nuijten, P.M. Engelfriet, K.J. Duijn, KJ, and M. Koopmanscha)

“Reality Check - Defining and Meeting the Practical Needs of Payers with Health Economic Evaluations,” Presented at the Fifth International Meeting, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, Virginia, May 2000

“Optimizing Operations Across a Multi-Site Unit: The Case of Specialty Physician Services,” Presented at the Spring Meeting of INFORMS, Washington, D.C., May 1996

“The New Drivers in Market Share - Disease Management Programs, Pharmacy Benefit Manager (PBM) Collaborations and How to Maximize Distribution,” Presented at the International Business Communications Conference on International Sales and Marketing for Biopharmaceutical Products, Lake Buena Vista, Florida, January 1995

“The Costs and Benefits of Pharmacoeconomics in Managed Care,” Presented at the Institute for International Research Conference on Methods and Applications for Pharmacoeconomic and Quality of Life Studies, San Francisco, California, November 1994

“Key Marketing Strategies for a Changing Healthcare System,” Presented at the American Managed Care Pharmacy Association Annual Conference, McLean, Virginia, October 1994

“Practical Applications for Pharmacoeconomic and Quality of Life Studies in Managed Care - A Workshop for Clinicians and Marketing Personnel,” Presented at the Institute for International Research Conference on Designing and Implementing Pharmacoeconomic and Quality of Life Studies, Philadelphia, Pennsylvania, April 1994

“HealthScript—Highly Targeted Marketing,” Presented at the Second Annual Claritas/NPDC Precision Marketing Conference, Baltimore, Maryland, June 1992

“Government Health Care Market Contracting Opportunities - Overview and Recommendations,” ASG/Prison Health Services, Incorporated, November 1990 (with S. Honiberg and M. Gabay)

“Interim Report - Evaluation of Products of Ambulatory Care (PACs) Program for Outpatient Medicaid Reimbursement in New York State,” Health Care Financing Administration (HCFA), November 1990 (with M. Noether and L. Olinger)

“Development of a Resource-Based Relative Value Scale (RBRVS) for Cardiothoracic and Vascular Surgery,” Society of Thoracic Surgeons, September 1990 (with M. Noether, M. Hecker, and H. Goldberg)

“Final Report to the College of American Pathologists - Design of Surveys for Pathology Practices - Assessment of Practice Costs for Use Under Medicare Reimbursement,” College of American Pathologists, May 1990 (with M. Noether, W.D. Marder, and J.D. Loft)

“Analysis Plan for the Child Nutritional Meal Cost Study,” Food and Nutrition Service, United States Department of Agriculture, February 1990 (with F.B. Glanz and C.W. Logan)

“Hospital Productivity and Service - Evaluation of the Veterans Administration System,” Policy Modeling Workshop, The University of Pennsylvania, September 1987 (with P. Durongaveroj)

“Resource Efficiency of Remedial Education Programs,” Presented at the American Educational Research Association Conference, San Francisco, California, April 1986

“Cost-Effectiveness of Remedial Education Programs,” The University of Pennsylvania and School District of Philadelphia, April 1986 (with A.P. Schinnar, A. Desai, S. Davidoff, and R. Fishman)

“Do Generic Drugs Really Cost Less?” Presented at the Association of Public Policy and Management Research Conference, Washington, D.C., November 1985

“Geriatric Services at the Family Medical Centers of the Philadelphia Department of Health - Evaluation of Services Provided and Recommendations for Performance Improvement,” Policy Modeling Workshop, The University of Pennsylvania, February 1984 (with L.C. Walters and A.P. Schinnar)

“Family Medical Centers in the Philadelphia Department of Health, Final Report - Performance Evaluation and Recommendations to Improve Fiscal and Operational Productivity,” Policy Modeling Workshop, The University of Pennsylvania, December 1983 (with A.P. Schinnar, L.C. Walters, and L. Wood)

Invited Lectures

“Transitions to Pay-for-Performance – MACRA – MIPS & APM,” Invited Lecture, HPM 5006 – Political & Economic Aspects of Health, College of Public Health, Temple University, Philadelphia, Pennsylvania, September 2017

“Executing a Global Strategy Optimizing Product Economics, Value, Pricing & ROI,” Invited Lecture, PB-880 – International Pharmaceutical Business, Mayes College of Healthcare Business & Policy, USciences, Philadelphia, Pennsylvania, July 2017

“MACRA – Redefining the Relationship Between Reimbursement and Quality, Engagement, Cost and Outcomes in Care,” Invited Lecture, PB-243 – Advanced Healthcare Systems, Mayes College of Healthcare Business & Policy, USciences, Philadelphia, Pennsylvania, March 2017

“MACRA as a Strategic Imperative – Leveraging Information & Analytics to Meet Requirements and Build System Capabilities,” Invited Lecture, Capstone Course in Health Informatics, College of Public Health, Temple University, Philadelphia, Pennsylvania, March 2017

“Health Information Exchange (HIE) in Practice – Creating Sustainable Value in Operation,” Pennsylvania Bar Institute (PBI), A Day on Health Law, Invited Session, October 2014, Philadelphia, Pennsylvania (with L.W. Clark)

“The Emerging Health Information Exchange (HIE) National Architecture – Building an HIE at the Community Level,” Pennsylvania Bar Institute, Health Law Institute (HLI), Invited Session, March 2014, Philadelphia, Pennsylvania (with L.W. Clark)

“Optimizing Drug Development by Defining Unmet Medical Need - Case Study in Multiple Sclerosis,” Invited Lecture, Principles and Practice of Drug Development, Sloan School of Management, MIT, Cambridge, Massachusetts, November 2002

“Options to Redefine the Current Business Model for Vaccine Development, Production and Access,” Invited Presentation, Bio-Defense Workshop, The Program on the Pharmaceutical Industry, Sloan School of Management and Office of Corporate Relations, MIT, Cambridge, Massachusetts, June 23–24, 2002

“Global Launch Strategies for Pharmaceutical and Biotech Products,” Invited Lecture, Economics of the Health Care Industries, Sloan School of Management, MIT, Cambridge, Massachusetts, April 2002

“Strategy, Positioning, Pricing and Payment for Biotech Products - Establishing & Maintaining Product Value,” Invited Lecture, Management and Economics of the Pharmaceutical, Biotech and Medical Device Industries, Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, February 2002

“Commercial Valuation, Product Potential and Market Positioning,” Invited Lecture, Economics of the Health Care Industries, Sloan School of Management, MIT, Cambridge, Massachusetts, February 2001

“Pricing and Positioning of Biotech Products,” Invited Lecture, The Management and Economics of the Pharmaceutical, Biotech and Medical Device Industries, Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, February 2001

“Commercial Manifestations and Business Model Ramifications - Linking R&D, Market Potential and Product Performance with Biopharmaceutical Products,” Invited Lecture, Principles and Practice of Drug Development, Sloan School of Management, MIT, Cambridge, Massachusetts, November 2000

“Implications for Industry - Evolving Business Models for Pharmaceutical and Biotechnology Firms,” Invited Lecture, Technology Driving Change in Drug Discovery, Development, and the Business of Pharmaceuticals, Sloan School of Management, MIT, Cambridge, Massachusetts, June 2000

Prior Experience

Corporate Partner—Executive Lead, Strategy, Value, Payment, The OCI Group, LLC, 2011-2021

Executive Lead—Government & Commercial Market Performance, MedImpact, 2006-2010

Senior Principal – Strategy, Operations & Payment, The Collaborative Group, LLC, 2003-2006

Senior Director, Global Pricing & Investment Strategy (GPIS), Wyeth (Pfizer) Pharmaceuticals, 1997-2002

Academic Appointments

St. Joseph’s University, Adjunct Professor – Health Informatics & Policy, 2017-2020

Professional Affiliations

American College of Healthcare Executives (ACHE) – Education & Programs Committee

Digital Medicine Society (DeMi)

Healthcare Financial Management Association (HFMA) – Decision Analytics & Risk Working Group, Follmer Merit Award

Healthcare Information Management Systems Society (HIMSS) – mHealth and Innovation Task Groups

Informs - The Institute for Operations Research & Management Sciences - Health Applications Section & Transfer Pricing Group

National Association of Business Economists (NABE) – Former Chair – Corporate Planning Roundtable

Society of Actuaries (SOA) – Medicaid & Behavioral Economics Work Groups

Additional Information

Additional Education Training

University of Pennsylvannia

  • University Fellow
  • Leonard David Institute of Health Economics (LDI) Fellowship

Marquette University - College of Business Administration

  • Non-Degree Student
  • Graded Coursework - Financial Accounting, Corporate Finance, MIS for Business

University of Wisconsin-Madison - Wisconin School of Business

  • Non-Degree Student
  • Graded Coursework - Capital Market Theory & Practice

On-Campus Executive Programs

  • Finance for Executives – Booth School of Business – University of Chicago
  • Executive Negotiation Workshop – The Wharton School – University of Pennsylvania
  • Business Dynamics – Diagnosing & Solving Complex Business Problems – Sloan School – MIT
  • Strategies for Sustainable Business – Sloan School – MIT

On-Line Skills Development

  • Machine Learning – Certificate Program – Stanford University – Coursera


Advisory Appointments

Health & Digital Health Portfolio – Ben Franklin Technology Partners

Health Technology & Digital Health – Dreamit Ventures

Knowledge

News & Events

CREDENTIALS & PROFESSIONAL HONORS

  • M.A., Public Policy Management, Wharton Kennedy School of Public Policy, University of Pennsylvania
  • B.A., Political Science, University of Chicago